The 2016 EU Healthcare Pioneers Report captures the best practice principles and case studies to show ways to improve detection (screening and diagnosis), protection (to prevent an AF-related stroke through anticoagulation therapy, with left atrial appendage closure an alternative for some patients who cannot be managed long term with anticoagulation therapy) and correction (treatment of the irregular heart rhythm).
This document is a framework service specification for the delivery of anticoagulation services for people with atrial fibrillation (AF). The specification was developed by Anticoagulation UK in close collaboration with experts in anticoagulation from across primary, community and secondary care. The standards within this framework reflect best practice for services to adhere to, both during and beyond the COVID-19 pandemic. This project has been fully funded by Bayer plc. The content is independent of and not influenced by Bayer plc who checked the final document for technical accuracy only.